Pacer Advisors, Inc. Kymera Therapeutics, Inc. Transaction History

Pacer Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$29.85 - $39.42 $13,850 - $18,290	-464 Reduced 47.3%	517 $15,000
Q1 2024 May 10, 2024	BUY	$22.9 - $43.57 $22,464 - $42,742	981 New	981 $39,000
Q2 2021 Jul 21, 2021	SELL	$31.08 - $51.95 $37,544 - $62,755	-1,208 Closed	0 $0
Q1 2021 Apr 05, 2021	BUY	$35.64 - $85.46 $43,053 - $103,235	1,208 New	1,208 $47,000

184

64.4M

50.6K

81.7K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.3B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.